Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis.
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 2014 Jun; 142(2):216-26.